241 related articles for article (PubMed ID: 2199847)
1. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis.
Greene P; Kang U; Fahn S; Brin M; Moskowitz C; Flaster E
Neurology; 1990 Aug; 40(8):1213-8. PubMed ID: 2199847
[TBL] [Abstract][Full Text] [Related]
2. Double-blind study of botulinum toxin in spasmodic torticollis.
Tsui JK; Eisen A; Stoessl AJ; Calne S; Calne DB
Lancet; 1986 Aug; 2(8501):245-7. PubMed ID: 2874278
[TBL] [Abstract][Full Text] [Related]
3. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis.
Gelb DJ; Lowenstein DH; Aminoff MJ
Neurology; 1989 Jan; 39(1):80-4. PubMed ID: 2642616
[TBL] [Abstract][Full Text] [Related]
4. Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients.
Lorentz IT; Subramaniam SS; Yiannikas C
Mov Disord; 1991; 6(2):145-50. PubMed ID: 2057005
[TBL] [Abstract][Full Text] [Related]
5. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A.
Greene PE; Fahn S
Mov Disord; 1993 Oct; 8(4):479-83. PubMed ID: 8232357
[TBL] [Abstract][Full Text] [Related]
6. Dysphagia after botulinum toxin injections for spasmodic torticollis: clinical and radiologic findings.
Comella CL; Tanner CM; DeFoor-Hill L; Smith C
Neurology; 1992 Jul; 42(7):1307-10. PubMed ID: 1620339
[TBL] [Abstract][Full Text] [Related]
7. A double blind trial of botulinum toxin "A" in torticollis, with one year follow up.
Moore AP; Blumhardt LD
J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):813-6. PubMed ID: 1955900
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance.
Comella CL; Buchman AS; Tanner CM; Brown-Toms NC; Goetz CG
Neurology; 1992 Apr; 42(4):878-82. PubMed ID: 1565246
[TBL] [Abstract][Full Text] [Related]
9. Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients.
Poewe W; Schelosky L; Kleedorfer B; Heinen F; Wagner M; Deuschl G
J Neurol; 1992 Jan; 239(1):21-5. PubMed ID: 1541964
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin treatment in spasmodic torticollis.
Blackie JD; Lees AJ
J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):640-3. PubMed ID: 2213040
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
[TBL] [Abstract][Full Text] [Related]
12. Local treatment of spasmodic torticollis with botulinum toxin.
Tsui JK; Fross RD; Calne S; Calne DB
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):533-5. PubMed ID: 3676924
[TBL] [Abstract][Full Text] [Related]
13. Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollis.
Koller W; Vetere-Overfield B; Gray C; Dubinsky R
Clin Neuropharmacol; 1990 Aug; 13(4):355-8. PubMed ID: 2208185
[TBL] [Abstract][Full Text] [Related]
14. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin in spasmodic torticollis.
Tsui JK; Eisen A; Calne DB
Adv Neurol; 1988; 50():593-7. PubMed ID: 3400512
[No Abstract] [Full Text] [Related]
16. A pilot study on the use of botulinum toxin in spasmodic torticollis.
Tsui JK; Eisen A; Mak E; Carruthers J; Scott A; Calne DB
Can J Neurol Sci; 1985 Nov; 12(4):314-6. PubMed ID: 4084867
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C; Swenson MR; Tarsy D; Murray JJ; Koller M; Wallace JD
Neurology; 1997 Sep; 49(3):701-7. PubMed ID: 9305326
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia.
Quagliato EM; Carelli EF; Viana MA
Clin Neuropharmacol; 2010; 33(1):22-6. PubMed ID: 19959960
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
Figgitt DP; Noble S
Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
